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1. Introduction 
Significant increase in noncommunicable diseases, in particular cardiovascular disease, in 
the past few decades worldwide represents one of the major health challenges in the overall 
global and social development of society. Cardiovascular conditions have the highest impact 
on lost years of life, lost quality of life, but also on the differences in longevity in different 
population groups. Global statistics show that cardiovascular conditions are responsible for 
one third of global deaths, while coronary heart conditions are the leading cause of death 
worldwide. (1,2) Many population research studies corroborated that high blood pressure is 
an independent and significant risk factor of cardiovascular disease and coronary heart disease 
and most significant determinant of morbidity and mortality in developed countries. (2,3) 
Constant increase in morbidity and mortality caused by cardiovascular disease, in particular 
high blood pressure as one of the most significant public health problem, evaluation of 
prevalence of high blood pressure and evaluation of control of high blood pressure in the 
population, including the distribution of cardiovascular risk factors altogether represent the 
basis for the modeling of an integrated risk and disease prevention program – an integrated 
management of hypertension in the community (4), which is effectively a step further in 
providing efficient, effective and high-quality health care.  
Globally health care is becoming more complex and more expensive and countries are now 
faced with various problems that need to be addressed in order to ensure sustainability of 
their health care systems. With the advance in technology, clinical treatment is also 
becoming more complex and more expensive so that countries are now more and more 
focused on preventive programs and controls of conditions which entail less direct costs. 
Key argument for introduction of preventive public health programs is that such programs 
have much bigger potential for long-term improvement of the population’s health status 
and also involve much lower costs than clinical medicine. (1,3) 
2. Cardiovascular diseases and leading risk factors 
A number of research studies clearly showed that cardiovascular disease can be attributed 
to unhealthy life styles and poor social and physical environment. Unhealthy diet, smoking, 
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physical inactivity and psychosocial stress are the leading risk factors for cardiovascular 
disease, as well as consequential manifestations of such life styles: hypertension, glucose 
intolerance and hyperlipidemia. These risk factors also reflect major preventable health 
problems. (5-12)) 
In the world the issue of cardiovascular disease became very pressing in early 1970s. At that 
time many health intervention program were planned at the level of the community and 
their purpose was to promote health and reduce detrimental life style changes. The basic 
starting premise was that the use of measures to reduce risk factors in population with 
clinically identified risk factors has only a limited effect on prevention of cardiovascular risk 
factor at the national level; on the other hand, global public health actions have more effects 
altogether. 
The first implemented program that was based on these ideas was the North Karelia Project 
carried out in Finland in 1972. This project achieved significant results, in particularly 
through the hypertension control programs. It started off as a pilot but after significant net 
reductions in both risk factors and cardiovascular disease-caused mortality rate, the project 
was rolled out to the national level. Over the next 25 years, smoking prevalence in men was 
significantly reduced and so was serum cholesterol and blood pressure levels. Over this 
period, mortality rate caused by cardiovascular disease in men aged 35-64 years dropped by 
68%, coronary heart disease mortality rate by 73%, cancer mortality rate by 44%, and 
mortality rate for all samples effectively dropped by 49%. (13-15) 
Building on this success, many projects have been implemented since then in the form of 
demonstrational projects under different WHO programs: CINDI (WHO/EURO), CARMEN 
(WHO/AMRO), and INTERHEALTH (WHO/HQ). Apart from clinical trials, all these 
projects involved different design, intervention approach, method, intensity, goals in 
reducing the risk factors, evaluation measurements and timeline. Major role of projects 
implemented in community is to demonstrate and stimulate health policies of non-
contagious disease prevention. (16) 
In their recommendations for 2003, the WHO and the International Society of Hypertension 
(ISH) defined three sets of risk factors required for monitoring in management of 
hypertension. (Table 1.) (28)  
Based on this, a stratification of overall cardiovascular risk factors was provided. Three 
major risk categories - low, medium and high risk - were calibrated to effectively indicate 
absolute likelihood of developing a cardiovascular disease in the next 10 years as follows: (1) 
low risk – less then 15%; (2) medium risk – 15-20%; and (3) high risk – over 20%. (Table 2.) 
3. Hypertension as a cardiovascular risk factor  
Nearly 1 billion of people worldwide are suffering from hypertension. Population research 
studies showed that 15-37% of adult global population is stricken by hypertension. The 
WHO statistics in 2002 showed that hypertension is the third leading cause of the global 
burden of disease. Untreated and non-controlled hypertension as highly prevalent risk 
factor for cardiovascular disease results in cerebrovascular accidents, myocardial infarction, 
heart failure and dementia, kidney failure and blindness. (2,3,4). 
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Cardiovascular disease risk 
factors 
Target organ damage (TOD) Associated clinical condition 
(ACC) 
1. SBP/DBP values (level 1-3) 
2. Man > aged 55 years 
3. Women > aged 65 years 
4. Smoking 
5. Total cholesterol > 6.1 mmol/l 
or  
LDL - cholesterol > 4.0 
mmol/l 
6. HDL - cholesterol 
Males < 1.0 mmol/l 
Females < 1.2 mmol/l 
7. History of cardiovascular 
disease in the first degree 
relatives before the age of 
50  
8. Obesity, physical inactivity 
 
 
 
 
1. Left ventricular 
hypertrophy 
2. Microalbuminuria (20-300 
mg/daily) 
3. Radiological or ultrasound 
evidenced extensive 
atherosclerotic plaque 
(aorta, carotids, coronary, 
iliac or femoral arteries) 
4. Grade 3 or 4 hypertensive 
retinopathy 
1. Diabetes mellitus 
2. Cerebrovascular 
conditions: 
• Stroke 
• Cerebral hemorrhage 
• Transitory ishemic 
attack (TIA) 
• Heart disease 
• Myocardial infarction 
• Angina pectoris 
• Coronary 
revascularization 
• Congestive coronary 
insufficiency 
3. Kidney diseases 
• Plasma creatinine   
concentrations 
• Females > 1.4 mg/dl 
• Males > 1.5mg/dl 
(120, 133 µmol/l) 
• Albuminuria 
>300mg/dnevno 
4. Peripheral arterial disease 
Source: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement 
on management of hypertension 
Table 1. Risk factors required for monitoring in hypertension management 
 
 
Other risks and history of 
disease 
Blood pressure (mmHg) 
Grade 1 mild 
hypertension 
SBP 140-159 
or 
DBP 90-99 
Grade 2 medium 
hypertension 
SBP 160-179 
or 
DBP 100-109 
Grade 3 severe 
hypertension 
SBP ≥180 
or 
DBP ≥110 
No other risk factors LOW MEDIUM HIGH 
1-2 risk factors MEDIUM MEDIUM HIGH 
3 or more risk factors or  
damaged target organs or 
diabetes mellitus 
HIGH HIGH HIGH 
Source: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement 
on management of hypertension 
Table 2. Stratification of risk in quantification of prognosis 
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Hypertension is estimated to cause 7.1 million of deaths worldwide or roughly 13% of total 
global morality. Significance of high blood pressure is becoming increasingly higher when it 
comes to disability caused by stroke and coronary ischemia, which expressed in DALY 
(Disability-Adjusted Life Year) that is 64.3 million DALYs of lost life or 4.5% of the total 
burden of disease. Each year globally there are 12 million fatal and approximately 20 million 
non-fatal myocardial infarctions, mostly in developing countries. Research showed that 
treated hypertension reduces risk of cerebrovascular accidents by 40% and risk of 
myocardial infarctions by 15%. (2,3,4) 
Even with extensive knowledge about the pathophysiology and the epidemiology of 
hypertension, simple diagnostics, availability of efficient drugs, hypertension still has high 
prevalence and as a result introduction of an effective hypertension control represents 
considerable public health challenge. (18,19) Public health systems worldwide continue to 
cope with inadequate management of hypertension and there is a need to ensure constant 
improvement of management by health professionals in order to make sure that at least two 
thirds of treated patients suffering from hypertension reach adequate control of blood 
pressure.  
In doing so it is necessary to perform control of major risk factors, such as smoking, obesity, 
increased total serum cholesterol and diabetes mellitus. (18,19) All this creates necessary 
prerequisites for setting up different methods of controlling hypertension that basically 
prevent continuation of costly cycle of clinical management of hypertension and the related 
complications. 
Definitions of hypertension, in particular in public health sense, are essentially pragmatic. 
They can be used and they were also defined to characterize a group of individuals who 
potentially may benefit from specific treatment regimes – non-pharmacological and 
pharmacological. Definition of hypertension which is more then 30 years old and which says 
that “Hypertension should be defined as the level of blood pressure which requires investigation and 
treatment to improve the condition” indicates that any numerical definition and categorization 
should be flexible and based on evidenced risk and availability of effective and well-
tolerated drugs. (20-24) Also clinically used definitions are rather arbitrary because of the 
nature of blood pressure distribution in the population. (25-27) Researchers have long 
discussed about threshold values of high blood pressure in different populations, in 
particular those threshold values that warrant therapeutic interventions. There is also 
variability in deciding the threshold values for evaluation of cardiovascular disease risk 
factor in individuals.  
Problem-based approach to hypertension is twofold: (i) it is described as a separate clinical 
entity/condition and is classified as a prevalent cardiovascular disease. Also hypertension is 
a very important factor in development of morbidity and mortality that are caused by 
cardiovascular disease; or (ii) it is described as intermediary (biological) factor in 
development of cardiovascular disease and conditions of circulatory system. In both cases 
hypertension is recognized as “an entry point” for the management of cardiovascular 
disease. 
The World Health Organization/International Society of Hypertension issued in 1999 and 
2003 guides for the management (diagnostics and treatment) of hypertension. The European 
Society of Hypertension (ESH) and the European Society of Cardiology (ESC) did not 
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develop their own guides but simply endorsed the WHO/ISH guides. As the number of 
population research studies and clinical trials in Europe increased and their results brought 
to light the new evidence, the European Society of Hypertension and the European Society 
of Cardiology developed for the first time in 2003 their own guides for the management of 
hypertension as a response to a suggestion by the WHO/ISH that regional experts should 
develop recommendations for the management of the disease based on regional conditions, 
depending on the degree of their health care and health care availability and their economic 
resources. (25) In 2007 these guides were updated based on the new clinical evidence. (28) 
As a result, a classification of blood pressure levels was made on the basis of the adopted 
definitions.(Table 3.) 
 
Category* Systolic pressure Diastolic pressure 
Optimal blood pressure <120 <80 
Normal blood pressure 120-129 80-84 
High normal blood pressure  130-139 85-89 
Grade 1 hypertension – mild 140-159 90-99 
Grade 2 hypertension – medium 160-179 100-109 
Grade 3 hypertension – severe ≥180 ≥110 
Isolated systolic hypertension ≥140 <90 
Isolated systolic hypertension should be graded (1,2,3) according to systolic blood pressure 
values in the ranges indicated, provided that diastolic values are < 90mmHg. Grades 1, 2 
and 3 correspond to classification in mild, moderate and severe hypertension, respectively. 
These terms have been now omitted to avoid confusion with quantification of total 
cardiovascular risk. 
 
Source: 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the 
Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the 
European Society of Cardiology (ESC) 
Table 3. Definitions and classification of blood pressure levels (mmHg) 
4. Situational analysis in the Federation of Bosnia and Herzegovina 
The Federation of Bosnia and Herzegovina is a part of Bosnia and Herzegovina. In April 
1992, Bosnia and Herzegovina was internationally recognised as a new independent country 
and became a member of the United Nations. War broke out in 1992 and ended with the 
signing of the Dayton Peace agreement in December 1995. The Peace Agreement established 
Bosnia and Herzegovina as a country of two entities and one district - the Federation of 
Bosnia and Herzegovina, Republika Srpska and District Brcko. The war 1992-1995 caused 
drastically demographic and epidemiological changes in Bosnia and Herzegovina. (29,30) 
The Federation of Bosnia and Herzegovina is currently going through a period of 
considerable political and economical transition which altogether has evident implications 
on the population’s health status. Changed lifestyles are result of transitional socioeconomic 
changes. Over the past two decades health reports have constantly showed high mortality 
and morbidity rates for noncommunicable diseases, in particular cardiovascular disease. 
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Hospital discharge rate statistics for these diseases is not analyzed at the Federation of 
Bosnia and Herzegovina level. (32)  
As the Federation of Bosnia and Herzegovina is currently going through a strong 
transitional and reform period of its socioeconomic development, its health system should 
be responsive to health and social needs of its population, especially at times when such 
needs turbulently change. Health system of the Federation of Bosnia and Herzegovina 
should be flexible and prompt to provide adequate and timely response to demographical 
and social changes, changes in epidemiological patterns of diseases, expectations of health 
care users for quality and their role in decision-making, inequity in health care system, and 
scientific an technological progress. (32,33) 
According to the official statistics of the Federation BiH Statistics Office, population of the 
Federation of Bosnia and Herzegovina in 2009 reached 2,327,318 with average population 
density at 89 people per square kilometer. Population of the Federation of Bosnia and 
Herzegovina falls under the category of stationary/regressive population with 14% of 
people over 65+ years of age. In the overall structure of the population, female population 
accounts for 51%. (34) According to the World Health Organization (WHO) estimates, life 
expectancy at birth for males is 73 and for female 78.  
The Federation of Bosnia and Herzegovina hypertension morbidity rate reported for 2009 
was almost 12% increase compared to the time before 1992 when practically started the 
period of strong political and socio-economic transition. The hypertension morbidity rates 
are not reliable, primary as a result of inconsistency of the health statistics system. Statistics 
available on morbidity rates originate from the primary health care and as such they are 
simply tip of an iceberg. In fact the statistics is based on the patient-requested health care, 
not on actual health needs of population. Assessment of actual health needs of the 
population requires additional sensitive research, such as cross-sectional research 
population studies. (31) This was the original idea in designing this particular research and 
assessment of the health needs. (30) 
In recent years, there have been several isolated population research studies in tthe 
Federation of Bosnia and Herzegovina which used different samples. Findings of one such 
study based on the CINDI methodology showed that unhealthy life habits have slightly 
increased in the population as a result of exposure to bad life habits such as smoking, 
unhealthy diet, physical inactivity, etc). (35) Wider public health implications of growingly 
unhealthy lifestyles are reflected in increased morbidity rates for chronic conditions and 
early disability, in particular those caused by cardiovascular disease. Statistics on awareness, 
treatment and control of hypertension in adult population of the Federation of Bosnia and 
Herzegovina are completely unreliable.  
5. The case study 
In order to effectively evaluate the prevalence of cardiovascular risk factors (overweight and 
obesity, smoking, history of hypercholesterolemia and diabetes mellitus) and also blood 
pressure values, a cross-sectional population study was carried out in the Federation of 
Bosnia and Herzegovina on a sample of adult population (aged 25-64 years), which was 
representative for the Federation of Bosnia and Herzegovina. (30) 
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The households were selected using the random sample method, following the survey 
conducted in the field. From each household one individual aged 25 to 64 years was 
selected. Stratified sampling allowed inclusion of both urban and rural areas within the 
selected municipalities.  
Original size of the sample was 3,020 households/respondents, which is effectively the 
internationally recommended sample size for evaluation of noncommunicable diseases risk 
factors in adult population. The survey was carried out in the autumn of 2002. Compared to 
the original sample (3,020 people), response rate was very high (91.5 %). Female 
respondents made 59 % of the total sample. 
Methodology of the survey fully complied with the international recommendations for 
survey protocol. (36-39) The survey involved interviews with and physicals measurements 
of individual respondents in their homes. The physicals measurements actually included 
blood pressure measurements.  
Hypertension awareness in the respondents was evaluated through a question listed on the 
survey questionnaire about whether the respondents being informed on high blood pressure 
by health professionals.  
Drug treatment of hypertension was evaluated by another question listed on the survey 
questionnaire. The term “treated” included the respondents who at that point were using 
antihypertensive drugs.   
Control of hypertension was evaluated by the question on awareness of their hypertension, 
use of antihypertensive drugs and measured value of blood pressure. 
The survey used a criterion for evaluation of hypertension prevalence which is normally 
used in population research studies. This criterion was based on the blood pressure 
threshold values and values of actual treatment by antihypertensive drugs. The 
respondents were hypertensive if they were using antihypertensive drugs and/or if their 
systolic blood pressure (SBP) was ≥ 140 mmHg and/or diastolic blood pressure (DBP) was 
≥ 90 mmHg.  
In addition to the above definitions, the research study also used the WHO/ISH definitions 
which categorize hypertension into three grades: mild, medium and severe. Following these 
definitions, mild hypertension included respondents who reported SBP of 140-159 mmHg 
and/or DBP of 90-99 mmHg; medim hypertension included respondents who reported SBP 
of 160-179 mmHg and/or DBP of 100-109 mmHg; and severe hypertension included 
respondents who reported SBP of > 180 mmHg and/or DBP of > 110mmHg. (see Table 3) 
Limitation of the survey is reflected in the categorization of hypertensive respondents based 
on one off blood pressure measurement, which in fact may lead to overrated hypertension 
levels, especially in patients who reported threshold values of SBP of 140mmHg and/or 
DBP of 90mmHg. 
Although cross-sectional research studies are not ideal tools for evaluation, they are 
necessary to obtain information about individuals who have no contact with health 
professionals in health care institution, individuals who are not aware of their hypertension, 
level of treatment and control of hypertension in different countries. Description of blood 
pressure patterns in the population and the underlying trends classified by age, sex, 
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education and other socioeconomic variables, actually allows development of strategies for 
reduction of morbidity and mortality caused by high blood pressure. 
5.1 Blood pressure  
Mean value of SBP was under 140 mmHg, while the DBP mean value was above 80 mmHg 
in both male and female respondents. Reported values were higher in female respondents.  
Age and gender structure showed that the lowest percentage of the respondents was from 
the youngest age group 25-34 years, males in particular. The highest number of respondents 
was from the age group 35-44 years, which proportionally included the highest number of 
females and males. (See Figure 1. ) 
174
328
347
451
321
422
279
428
25-34 yrs of age 35-44 yrs of age 45-54 yrs of age 55-64 yrs of age
Males
Females
  
Fig. 1. Number of respondents by age and gender 
χ2(3)=12.5, p<.006 
Mean value of SBP in male respondents was 132 mmHg and in female respondents it was 
135 mmHg. The difference was statistically significant (p < 0.001) (See Table 4.). Mean value 
of DBP was 84 mmHg in both genders. As with the SBP, mean value of DBP also increased 
with the age of the respondents.  
5.2 Prevalence of hypertension 
Following the definition of hypertension whereby the respondents were hypertensive if they 
were using antihypertensive drugs and/or if their SBP was ≥ 140 mmHg and/or DBP was ≥ 
90 mmHg. Total of 41% respondents were hypertensive (Table 5.) 
Prevalence of hypertension was 36% in male and 45% in female respondents. Proportion of 
the respondents with hypertension statistically increased to a significant degree in both 
female and male respondents (p < 0.0001), but slightly higher in female respondents in 
elderly age group (aged 45 to 64 years). (See Table 6.). 
In addition to the above definitions, as already mentioned, the research study also used the 
WHO/ISH definitions which categorize hypertension into three grades: mild, medium and 
severe. Following these definitions, mild hypertension included respondents who reported 
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SBP of 140-159 mmHg and/or DBP of 90-99 mmHg; medim hypertension included 
respondents who reported SBP of 160-179 mmHg and/or DBP of 100-109 mmHg; and 
severe hypertension included respondents who reported SBP of > 180 mmHg and/or DBP 
of > 110mmHg. (See Table 3.) 
 
Age 
(years) 
 
Males 
 
Females 
Mean value
 
(SD) N Mean value (SD) N 
Systolic blood 
pressure 
      
25-34 124 (10.8) 172 119 (12.8) 325 
35-44 128 (13.2) 346 126 (17.8) 450 
45-54 134 (16.5) 320 141 (24.5) 419 
55-64 142 (23.7) 279 150 (25.1) 426 
Total 132 (18.1) 1117 135 (24.2) 1620 
Diastolic blood 
pressure 
      
25-34 79 (8.2) 172 77 (8.6) 325 
35-44 83 (8.0) 346 81 (10.1) 450 
45-54 85 (9.1) 320 87 (12.3) 419 
55-64 87 (10.9) 279 90 (12.9) 426 
Total 84 (9.4) 1117 84 (12.3) 1620 
Table 4. Systolic and diastolic blood pressure (mean value and SD), by age and gender 
 
Age 
(Years) 
 
Normotensive Hypertensive 
N % N % 
Grade 1 hypertension 
25-34 422 88 58 12 
35-44 572 73 213 27 
45-54 372 50 365 50 
55-64 220 31 482 69 
Total 1586 59 1118 41 
Table 5. Prevalence of hypertension by age 
Prevalence of mild hypertension was equally distributed in both female and male respondents. 
Proportion of respondents suffering from mild hypertension statistically increased 
significantly with the age of both female and male respondents (p < 0.0001). Prevalence of 
moderate and severe hypertension was higher in female respondents. (See Table 7.). 
Prevalence of hypertension on the threshold value of 140 and/or 90 mmHg among the adult 
population of the Federation of Bosnia and Herzegovina was higher than in some countries 
in this part of Europe, including Albania and Hungary. Cross-sectional research studies 
carried out in Albania and Hungary in recent years showed much lower prevalence of 
hypertension which in Albania was reported at 32% and in Hungary at 37%. (40,41) 
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Furthermore, compared to findings of research studies carried out in developed European 
counties (e.g. UK, Germany) in the past 10 years, where prevalence of hypertension was 38% 
and 32% respectively (and it was much lower in female respondents), prevalence of 
hypertension in the Federation of Bosnia and Herzegovina is quite high. (42,43) This 
altogether should be a challenge for public health of the Federation of Bosnia and 
Herzegovina in order to effectively identify potential additional risk factors. 
 
Age 
(Years) 
 
Normotensive Hypertensive 
N % N % 
Males     
25-34 145 88 20 12 
35-44 254 75 86 25 
45-54 190 60 129 40 
55-64 120 43 158 57 
Total 709 64 393 36 
Females     
25-34 277 88 38 12 
35-44 318 71 127 29 
45-54 182 43 236 57 
55-64 100 24 324 76 
Total 877 55 725 45 
* The respondent were classified as hypertensive if they were using antihypertensive drugs and/or if 
their systolic blood pressure was > 140 mmHg and/or diastolic blood pressure was > 90 mmHg 
Males χ2(3)=113.3, p<.0001; Females χ2(3)=377.6, p<.0001 
Table 6. Prevalence of hypertension by age and gender 
Age 
(Years) 
 
Normotensive 
Grade 1 
Mild 
hypertension 
Grade 2 
Moderate 
hypertension 
Grade 3 
Severe 
hypertension 
N % N % N % N % 
Males*         
25-34 151 88 18 10 2 1 1 1 
35-44 261 75 73 21 9 3 3 1 
45-54 196 61 91 28 27 9 6 2 
55-64 131 47 88 32 37 13 23 8 
Total 739 66 270 24 75 7 33 3 
Females**         
25-34 290 89 32 10 3 1 0 0 
35-44 330 73 92 20 19 5 9 2 
45-54 193 46 126 30 59 14 41 10 
55-64 123 29 134 31 109 26 60 14 
Total 936 58 384 24 190 12 110 6 
*χ2(9)=128.6,  p < .0001 
** χ2(6)=394.2,  p < .0001 
Table 7. Prevalence of hypertension by age and gender (clinical classification of 
hypertension) 
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5.3 Awareness of hypertension, treatment and control of hypertension  
Almost 54% of hypertensive respondents were not aware of their hypertension. Very high 
79% of the hypertensive respondents who are aware of their hypertension were 
pharmacologically treated, which indicates relatively good availability of antihypertensive 
drugs. Of the total number of respondents who were pharmacologically treated, the 
condition was adequately controlled in only 13%. Generally female respondents were more 
aware of their hypertension and they were more regularly treated and controlled then male 
respondents. 
In the hypertensive respondents there was a statistically significant difference between the 
genders with respect to the degree of awareness, treatment and control of hypertension. 
There were 63% of hypertensive male respondents who were not aware of their 
hypertension as opposed to 50% of females in this particular category of respondents. 
Hypertension treated but not controlled respondents included 24% male and 34% female 
respondents. Percentage of the hypertensive respondents who were both treated and 
controlled was relatively low - 5% in male and 6% in female respondents. (See Figure 2.) 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Males Females
Hp, treated,
controlled
Hp treated, non-
controlled
Hp, untreated
Hp, unaware
 
Fig. 2.  Awareness, treatment and control in hypertensive respondents, by gender 
In genders there was a statistically significant difference among the age groups with regards 
the degree of awareness of hypertension, treatment and control of hypertension. The degree 
of awareness of hypertension in both genders significantly increases with the age of the 
respondents. There were more hypertensive, treated, and non-controlled respondents in 
older age groups (45 to 64 years) and the portion significantly increased with the age of the 
respondents. Percentage of hypertensive, treated, and controlled respondents was low at 
males 5% and females 6%). (Table 8.) 
The low rate of detection and control of hypertension in hypertensive respondents can be 
attributed to the lack of standardized integrated programs for reduction of hypertension or 
at least developed screening programs at the Primary health care (PHC) level. The degree of 
detection, treatment and control of hypertension increased with the age of the respondents 
as prevalence of hypertension increased.  
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Hypertensive, 
Unaware 
Hypertensive, 
untreated 
Hypertensive, 
treated, 
non-controlled 
Hypertensive, 
treated, 
controlled 
N % N % N % N % 
Males         
25-34 19 95 0 0 1 5 0 0 
35-44 75 87 6 7 1 1 4 5 
45-54 81 63 15 12 28 22 5 4 
55-64 74 47 11 7 63 40 10 6 
Total 249 63 32 8 93 24 19 5 
Females         
25-34 29 77 6 16 0 0 3 8 
35-44 80 63 16 13 23 18 8 6 
45-54 126 53 27 11 72 30 11 5 
55-64 123 38 26 8 153 47 22 7 
Total 358 50 75 10 248 34 44 6 
Table 8. Awareness, treatment and control in hypertensive respondents by age and gender 
6. Control of hypertension 
Experiences of good practice exercised in various countries have showed that significant 
progress in health can be made through a well organized and focused approach to 
prevention, treatment and control of the disease, which should be a part of any health 
system. This is possible to achieve in social environments which support intervention 
programs in community. In order to make this happen, major changes need to be made in 
the areas of health policies, organization of health, training/academic education of health 
professional who also need to be properly equipped. Ultimately, such approaches do not 
require considerable resources compared to highly complex clinical interventions. (2,3,4) 
Following the general managerial approach, the World Health Organization introduced in 
mid 1980s a number of integrated programs for prevention and control of disease that 
were defined as “programs that combine resources and approaches to prevention and control of 
selected diseases and related conditions and programs that will allow managerial unification of 
activities that will lead to prevention and control of diseases and promotion of health in overall 
community.” (4) 
Integrated management of disease and risk factors is particularly recommended in countries 
with limited financial resources for health care. Mechanisms of such integrated approach 
can be used to evaluate actual health needs, develop manuals to be used at all levels of 
management, supervision, adequate treatment and mobilization of community in support of 
the population’s health. 
One of well-founded approaches and an example of good practice is Integrated 
Management of Childhood Illness (IMCI) which is very efficient and applicable in 
developing countries as more than 80 developing countries has adopted the IMCI as their 
national policy aimed at improving children’s health. This approach allows provision of 
children’s health care in an efficient and effective way. (2) 
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Since non-communicable diseases, in particular cardiovascular disease, are leading cause of 
global morbidity and mortality, defining an integrated management of cardiovascular 
disease, including risk factor management, represents a major challenge for the national 
health systems worldwide. The modeling of an integrated management of non-
communicable diseases means improved supervision and monitoring, development and 
implementation of intervention prevention programs for different target population groups, 
implementation of intervention programs in the community and advocacy in public policies 
with considerable support for health care services. The model of integrated management 
should promote rational allocation of resources, evidence-based treatment, cost-
effectiveness and self-management strategies aimed at achieving improved health outcomes 
through full involvement of the entire community. (44,45) 
The integrated approach to control of hypertension is innovative in shifting the paradigm 
from “treatment of hypertension” to “management of hypertension” as an integrative 
program in control of risk factors such as high cholesterol, obesity and diabetes mellitus. 
This movement to an innovative approach is supported by evidence of cost-effectiveness of 
managerial approaches to the integrative control of hypertension in the population. 
Therefore the developing of an integrated hypertension management model at the level of 
the community should be supported in the country as the original, flexible approach and 
comprehensive package that combines different sustainable activities that will produce a 
synergic effect in fight against selected risk factors. (46-48) 
Population approaches in dealing with the health needs of the population are the bigger 
challenge with the long-term results. Epidemiological theories confirmed by research 
studies have indicated that intensive treatment of individuals who are under a threat of high 
risk of developing a disease have actually yielded limited progress in reducing general risk 
in the population as opposed to the population approaches. (49-51)  
This effectively corroborate the fundamental axiom of preventive medicine which says that 
a large number of people exposed to small risk can result in much bigger number of cases 
that the small number of people exposed to high risk.(2) 
However, effective and efficient control of blood pressure in the population requires two 
approaches: population approach and individual approach to high risk individuals. Both 
approaches are necessary and complementary for effective control and management of 
hypertension in the community. It is important to specifically note that balanced 
combination of population preventive strategy and preventive strategy in dealing with the 
high risk individuals is vital for effective control of epidemic and growing burden of non-
communicable in the community in general, in particular hypertension and cardiovascular 
disease. (See Figure 3) (2,4) 
7. Strategies for reducing high blood pressure 
Despite many efforts to diagnose and effectively treat hypertension, this condition is still the 
leading cause of cardiovascular morbidity and mortality. This is why it is very important to 
improve unsatisfactorily treatment and control of hypertension globally. According to the 
research studies published by the WHO, major barriers for adequate management of 
hypertension include lack of standardized clinical guides at the national level, inadequate 
training of health professionals in management of hypertension and poor availability of 
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hypertension drugs at the Primary health care level. Development of management of 
hypertension in public health context represents the best way to introduce the management 
of cardiovascular risks. (52,53)  
 
Fig. 3. Population vs. individual approach in improved health of the population  
For the most part, successful implementation of guides and recommendations requires a 
multidisciplinary approach, from mass dissemination of recommendations, provision of public 
health education programs direction in the field, all the way to clinical treatment of ill patients. 
To achieve all this it is necessary to ensure involvement of lager number of stakeholders, from 
strategic to operational levels of management. Formal approval of guides essentially depends 
on national associations of hypertension and professional associations, in order to promote the 
proposed changes in behavior and improve prognosis for patients. (54-59) 
Leading non-communicable diseases, including hypertension, are associated with common 
preventable risk factors – obesity, smoking and increased levels of fats in the blood. Better 
understanding of these risk factors and their determinants means better opportunities for 
prevention and control of the associated non-communicable diseases. Early detection and 
understanding of extent of this health issue, early warning and early response altogether 
allow timely prevention of future epidemic and “explosion” of risk factors. (60,61) 
High rate of undetected hypertension and unsatisfactorily control of hypertension indicate 
that hypertension today is insufficiently and inadequately treated. This results in far 
reaching consequences in development of heart-, brains- and kidney-related conditions and 
eventually fatal outcomes. At this point the health system of the Federation of Bosnia and 
Herzegovina is treating adverse health outcome and the sequels. Number of complicated 
cardiac surgeries is on the rise and this in fact puts additional strain on already limited 
health sector budget allocations. 
Lessons from many countries which developed the comprehensive policies showed that 
there is a significant reduction in mortality caused by cardiovascular disease. In Finland, for 
example, the comprehensive strategy that effectively combined prevention, promotion in 
the community and the approach to the treatment resulted in decrease of mortality rate by 
staggering 60%.  
Two preventive strategies are described in the scientific literature: population and 
individual strategy.  
Population strategy in reducing high blood pressure in countries throughout the world is 
very cost-effective – it is especially suitable for countries with limited resources such as 
Bosnia and Herzegovina. Population strategy allows potential control of incidence of 
disease in the population. With respect to hypertension, this approach includes reduction of 
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mean value of blood pressure in the population by shifting the entire distribution towards 
the left lower values (distributional transition – a shift from the current values towards the 
desired value and planned scenario) and reduction of prevalence of high blood pressure and 
hypertension in adult population in elderly age as well. (See Figure 4.) Population approach 
strongly supports promotion and improvement of cardiovascular health of the population. 
INTERSALT study showed that population measures which can reduce mean value of 
systolic blood pressure by 2-3 mmHg can also reduce prevalence of hypertension in the 
population by one fifth at the age of 20 to 59 years. This means that organized, focused and 
controlled measures put in place in the population/community can successfully lead to 
distributional transition. (62) 
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Fig. 4. Distribution of SBP in adult respondents and directions of distributional transition by 
gender 
Population approach supports identification and modification of risk factors associated with 
different behaviors such as, for example, dietary habits, smoking and physical inactivity. 
Multiple interventions with regards the risk factors are possible by setting up health policies 
in the country through the multisectorial approaches in the community. Managerial 
approach to the population/community requires active involvement of large number of 
stakeholders from all three levels of management (strategic, tactical and operational) in 
health sector which is the primary public sector for the starting of such initiative. 
It is described in the scientific literature that interventions aimed at changing the unhealthy 
lifestyles are very successful in reducing the absolute risk of development of hypertension in 
the population. (52,63,64) Preventive strategies implemented in young population, or rather 
in early stages of life, allow long-term potential for prevention of conditions which lead to 
development of hypertension and high blood pressure, as well as for reduction of overall 
morbidity and complications associated with conditions caused by high blood pressure. (53) 
On the other hand, individual approach in prevention of disease does not provide a big 
picture of causes of diseases in the environment and projections of potential trends of the 
disease. However, it requires continuous and considerable screening of new highly risk 
individuals. Individual approach to high risk individuals with respect to hypertension 
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includes detection, treatment and effective control of high blood pressure. Such approach 
requires effective treatment and both modification of lifestyle and pharmacological 
treatment. 
It is necessary to create prerequisites necessary to study the approach to high-risk 
individuals which in fact primarily includes detection, early diagnosis and start of a 
treatment of hypertension. Changes to attitudes of health professionals in terms of the 
integrated hypertension management can be achieved through formal education of health 
professionals.  
Based on the international recommendations, tables of cardiovascular risk stratification are 
recommended for management of hypertension at the level of an individual. Cardiovascular 
risk assessment systems have been for the most part developed on the findings of the 
Framingham Risk Score study. (65,66) Recent SCORE project developed the risk assessment 
tables to estimate the probability of developing fatal cardiovascular disease within the next 
10 years, in particular for high-risk countries in the north of Europe and low-risk countries 
in the south of Europe.(67)) These categories can be used as indicators for assessment of 
relative risk in the population. It is recommended that the countries adapt the risk 
stratification tables and to introduce them in daily practice. The SCORE tables are based on 
risk assessment relative to values of cholesterol and blood pressure and age and gender. 
8. Model of integrated hypertension management in community  
Based on the survey results, it has become necessary to introduce a model of integrated 
management of hypertension in the Federation of Bosnia and Herzegovina at this point 
because of the relatively high prevalence of hypertension and leading cardiovascular risk 
factors.  
In the countries with limited budgetary allocations for health, such as the Federation of 
Bosnia and Herzegovina, population prevention strategies are the most cost-effective 
solution. (2, 68) These strategies control incidence of risk factors in the population, their goal 
is to change health behavior and reduce exposure to risk factors and also to reduce risk in 
the entire population. Potential benefits are high but there are challenges as well because the 
community largely benefits from preventive measures while it seems that such measures 
produce limited benefits for an individual. This, on the other hand, may cause a negative 
motivation in the population and this is described as “preventive paradox.” Therefore it is 
necessary to use the both approaches complementary. The key challenge is to find a suitable 
balance between the population approach and the approach to high-risk individuals. (69) 
Managerial approach to the community (to the population) requires active involvement of 
large number of stakeholders from all three levels of management (strategic, tactical and 
operational) in health sector which is the primary public sector for the starting of such 
initiative.  
Role of strategic management in the health sector (a country’s government) in reduction of risk 
is significant. The government should act as an advisor in the initiative to reduce the risk 
factors – selected, highly prevalent in the population and widely distributed risks. One of 
potential instruments include the passing of legislation, which is more cost-effective as it is 
assumed that the legal regulations will more readily lead to changes in agreements rather than 
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professional recommendations alone. Both approaches require consultations with a large 
number of active stakeholders and the multisectorial approach. (See Table 9.,) Unfortunately 
transition countries, such as the Federation of Bosnia and Herzegovina, have a poor 
regulatory structure and they are more dependable on the non-controlled market. Against 
such backdrop, it is necessary to select sustainable and implementable measures, including, for 
example, higher taxes on tobacco products, legislation on reduced salt content in industrially 
produced food products, use of mandatory content labeling of products, support for 
production of healthy food or subsidization of price of food produced by local producers. 
 
Levels of  
management 
 
Possible interventions 
Responsible 
organizations  
Theoretical 
coverage of 
population  
Strategic 
management 
1. Legal regulations on reduced 
content of salt in local industrially 
produced food products and 
mandatory food product content 
labeling 
 
Government of the 
country 
 
100% 
Tactical 
management 
1. Health education through mass 
media 
2. Campaigns 
3. Introduction of risk screenings 
4. Development of diagnostics and 
therapeutic protocols 
5. Training for health professionals 
6. Development of reference 
programs such as the School of 
Hypertension in Community 
 
Public health 
institutes, medical 
associations, 
professional 
associations, non-
governmental 
organizations 
 
60-80% 
Operational 
management 
1. Pharmacological treatment and 
patient education on lifestyles 
including dietary counseling for 
individuals with SBP over 160 
mmHg or 140 mmHg. 
2. Pharmacological treatment and 
patient education on lifestyles 
including dietary counseling for 
individuals with cholesterol serum 
concentration of over 5.7 mmol/l. 
3. Nicotine replacement therapy with 
medical consultations by physician. 
4. Triple therapy treatment for 
reduction of high blood pressure for 
individuals with absolute risk of 
cardiovascular events of 5% (15, 20, 
25%) over the next 10 years. 
5. Development of hypertension 
consultation facilities. 
 
PHC 
Hospitals 
 
 
26-41% 
Table 9. Cost-effective interventions in reducing prevalence of hypertension 
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Role of tactical management in health sector, such as public health institutes, medical 
associations, professional physician associations, is reflected in designing, introducing and 
implementing intervention programs in the community through a series of mapped 
activities including preparation of culturally-sensitive promotional and preventive 
education messages, services aimed at supporting the changed lifestyles, introduction of risk 
screenings, development of diagnostic and therapeutic protocols, training for of health 
professionals and development of reference programs. 
Role of operational management in the health sector, such as primary, secondary and 
tertiary health care levels (hospitals, clinics and health resorts) and non-governmental sector 
is reflected in the active implementation of recommendations, design and dissemination of 
written materials and active participation in the health training/education. 
These interventions could be used as strategies in creation of population approach in 
management of hypertension. 
Findings of this research study showed that prevalence of detection and prevalence of 
control of hypertension were relatively low, which further supports the importance of 
introducing the integrated management of hypertension.  
Based on evaluation of prevalence of hypertension and distribution of major cardiovascular 
factors in the population research study, the managerial approach was assumed, through all 
developmental stages of the process (input, process and output) for for hypertension. (See 
Figure 5. ) 
Input included input variables (income) and resources (actual input). 
Input variables (income) included:  
1. High prevalence of hypertension in the population (41%),  
2. High prevalence of selected major cardiovascular risk factors (27% in both genders) 
3. High prevalence of smoking in young males aged 25 to 44 years (56%)  
4. High prevalence of obesity in middle-aged women aged 35 to 54 years (35%).  
Actual input included required resources: 
1.  Staff 
2. Premises 
3. Equipment 
4. Time 
5. Money 
Process included supervision, stakeholders and activities.  
1. Supervision included formal bodies such as steering committees of projects 
implemented in the community or intervention programs which targeted subgroups 
within the population. 
2. Implementers included predominantly the health sector experts from different 
implementation sites (Family Medicine Ambulantas, work places, schools). 
3. Activities were linked together through project cycles, with clearly defined goals, 
performance indicators and monitoring that was carried out. (See Table10.) 
Output included output variables and outcome.  
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Output variables were: 
1. Process evaluation of the project (resources, process, monitoring) 
Outcome and impact was: 
1. Degree of achieved value – achievement of the desired quantified goal. 
 
GOAL – WHAT? PROCESS - HOW? LOCATION - WHERE? TIME - WHEN? 
1. Reduced  prevalence 
of hypertension by 
10% in adult 
population 
 
 
Legal regulations on 
reduced content of salt 
in local industrially 
produced food 
products and 
mandatory food 
product content 
labeling
THE COMMUNITY 
 
Coverage 
100% of the population 
CONTINUOUSLY 
2. Reduced mean value 
of blood pressure in 
the population 
(distributional 
transition) aimed at 
promoting and 
improving 
cardiovascular health 
of the population 
Develop the reference 
program the School of 
Hypertension in the 
Community 
 
THE COMMUNITY
 
Coverage 
100% of the population 
 
1. Health professionals – Family 
Medicine teams (PHC) 
2. Support groups – healthy 
population 
3. Population under the risk 
4. Representatives of mass media
ONE-YEAR 
CONTROLLED 
PROGRAM IN 
LOCAL 
DEMONSTRA-
TIONAL AREAS 
3. Reduced smoking 
by 10%, especially in 
young males 
- Campaigns on 
possible use of nicotine 
replacement therapies 
with medical counseling 
by physician. 
- Health education 
through the mass media 
– TV shows on how to 
quit smoking
Big shopping centers, places 
which people of this age normally 
visit (entertainment and sports 
venues), sports non-
governmental organizations, 
TV stations 
 
Coverage 
55% of male population 
ONE-YEAR 
CONTROLLED 
PROGRAM IN 
LOCAL 
DEMONSTRA-
TIONAL AREAS 
4. Reduced obesity by 
10%, especially in 
middle-aged women 
- Health education 
through the mass media 
– TV shows on 
importance of physical 
activity 
- On-the-job education
- Promotion of recipes 
for low-calorie meals
TV stations 
big shopping centers, women’s 
non-governmental organizations
 
Coverage 
40% of female population 
ONE-YEAR 
CONTROLLED 
PROGRAM IN 
LOCAL 
DEMONSTRA-
TIONAL AREAS 
Table 10. Activities proposed in managerial process of intervention programs in the 
community – population approach 
These interventions could be used as strategies in creation of population approach in 
management of hypertension. Findings of this research study showed that prevalence of 
detection and prevalence of control of hypertension were relatively low, which further 
supports the importance of introducing the integrated management of hypertension. The 
individual approach is better suited for high prevalence of hypertension. Compounded by 
the high prevalence of major cardiovascular factors, detection, adequate treatment and 
control are placed at (70)  
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Fig. 5. Integrated management of blood pressure in the community (Intervention programs 
in the community) 
9. Recommendations 
1. Ensure support to healthy policies in the country by introducing a number of 
multisectorial approaches in the community that will allow multiple interventions in 
reducing the risk factors. The community is a significant partner and the vital point in 
achieving the goals that have been set. 
2. It is necessary to develop a model of integrated management of hypertension and major 
cardiovascular risk factors as a comprehensive model introduced in the community that 
should be primarily directed towards modification of a detrimental lifestyle. 
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3. Health care should be restructured in order to effectively provide integrated health care 
through changed attitudes of health professionals, availability of technologies used for 
diagnostics and treatment of hypertension and improved quality of the referral system 
that will reduce inequities in the health. 
4. With regards to the findings of the research study, purpose of the integrated 
hypertension program should be reduction of high blood pressure in adult population, 
with the following specific objectives –  
• Raise awareness of hypertension in hypertensive individuals through efficient 
detection of hypertensive individuals by health professionals through improved 
monitoring, in particular at the level of Primary health care; 
• Introduce standardized and suitable diagnostic and therapeutic protocols to be 
used by health professionals – efficient monitoring and treatment of hypertension; 
• Improve control of hypertension in hypertensive individuals; 
• Allow effective collection of data on epidemiology of hypertension. 
5. Strong support to development of population approach in the managerial process of 
implementation of intervention programs of blood pressure control that will promote 
reduction of mean value of blood pressure in the population (distributional transition) 
in order to improve and advance cardiovascular health of the population. 
In the light of the above recommendations, these activities should be focused on clear 
identification of health needs. Carefully planned, well designed and well implemented 
programs of disease control, either population or individual, represent a strong sole 
instruments to effectively deal with the problem of morbidity through the use of preventive 
measures. (71,72)  
Prevention of disease is crucial to human development. Through such approach, it will be 
possible to reach different groups of the population, which will in turn facilitate equity in 
health. (31,33.) 
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